Recombinant MERS Coronavirus Spike Glycoprotein (S1), His-tagged
Specification
Related Products
| Cat#: |
HUM-312 |
| Product Name: |
Recombinant MERS Coronavirus Spike Glycoprotein (S1), His-tagged |
| Description: |
MERS Coronavirus Spike Glycoprotein (S1), His-Tag is a recombinant protein, cloned and expressed in E. coli. |
| Gene: |
S1 |
| Species: |
MERS Coronavirus |
| Source: |
E. coli |
| Synonyms: |
MERS Coronavirus Spike Glycoprotein (S1) |
| Purity: |
Purity >95% as determined by 10% PAGE (Coomassie staining). |
| Notes: |
This product is intended for research and manufacturing uses only. It is not a diagnostic device. The user assumes all responsibility for care, custody and control of the material, including its disposal, in accordance with all regulations. |
| Applications: |
For use in ELISA and other immunoassays. |
| Tags: |
C-terminal 6xHis |
| Background: |
Middle East respiratory syndrome (MERS), also known as camel flu, is a viral respiratory infection caused by the MERS-coronavirus (MERS-CoV). MERS-CoV is a betacoronavirus derived from bats. Since April 2012, cases of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) have been identified in middle east and other countries, causing severe illnesses with ~35% mortality. Spread between humans typically requires close contact with an infected person. Camels have been shown to have antibodies to MERS-CoV but the exact source of infection in camels was not identified. Camels are also believed to be involved in transmission to humans. MERS-CoV genomes are phylogenetically classified into two clades, Clade A and B. Early cases of MERS were of Clade A clusters (EMC/2012 and Jordan-N3/2012), whilst more recent cases have been Clade B (Chu et al., 2014).
Three MERS-CoV proteins are expressed on the envelope of the virus: the surface spike protein (S), the membrane glycoprotein (M), and the envelope protein (E). The S protein is responsible for viral entry via attachment to and fusion with the host cell membrane. Spike protein has two domains, S1 and S2; the S1 domain is responsible for cellular tropism and interaction with target cell, whilst the S2 domain is responsible for membrane fusion. MERS-CoV has pandemic potential but there is currently no specific vaccine or treatment for the disease. However, the C terminus of S1 contains a receptor binding domain with potential for vaccine development and use in diagnostics (Xu et al., 2019). To this end, a peptide from amino acids 56 to 295 of spike protein S1 was expressed and purified from E. coli, with a 6 x His tag is attached to its C-terminus. |
For research or industrial raw materials, not for personal medical use!
